本页面由Tiger Trade Technology Pte. Ltd.提供服务

再鼎医药

20.59
+0.26001.28%
盘后20.590.00000.00%17:48 EDT
成交量:90.31万
成交额:1,869.69万
市值:23.13亿
市盈率:-12.70
高:21.33
开:20.46
低:20.39
收:20.33
52周最高:44.34
52周最低:15.96
股本:1.12亿
流通股本:1.09亿
量比:1.00
换手率:0.83%
股息:- -
股息率:- -
每股收益(TTM):-1.6209
每股收益(LYR):-1.6026
净资产收益率:-24.19%
总资产收益率:-13.36%
市净率:3.49
市盈率(LYR):-12.85

数据加载中...

2026/05/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/07

重要事件披露

Form 8-K - Current report
2026/04/06

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities